Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case
Igår, 16:13
10:13 AM EDT, 05/18/2026 (MT Newswires) -- The US Supreme Court on Monday denied petitions for writs of certiorari filed by six big pharmaceutical companies seeking to challenge the legality of the so-called 'Drug Price Negotiation Program'under the Inflation Reduction Act of 2022.
AstraZeneca (AZN), Novartis (NVS), Novo Nordisk (NVO), Johnson &Johnson's (JNJ) Janssen Pharmaceuticals, Bristol Myers Squibb (BMY) and Boehringer Ingelheim Pharmaceuticals all had their petitions denied by the Supreme Court.
The companies did not immediately respond to requests for comment from MT Newswires.
Price: 183.25, Change: +1.67, Percent Change: +0.92
Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case
Igår, 16:13
10:13 AM EDT, 05/18/2026 (MT Newswires) -- The US Supreme Court on Monday denied petitions for writs of certiorari filed by six big pharmaceutical companies seeking to challenge the legality of the so-called 'Drug Price Negotiation Program'under the Inflation Reduction Act of 2022.
AstraZeneca (AZN), Novartis (NVS), Novo Nordisk (NVO), Johnson &Johnson's (JNJ) Janssen Pharmaceuticals, Bristol Myers Squibb (BMY) and Boehringer Ingelheim Pharmaceuticals all had their petitions denied by the Supreme Court.
The companies did not immediately respond to requests for comment from MT Newswires.
Price: 183.25, Change: +1.67, Percent Change: +0.92
Evolution
Evolution
Marknadsöversikt
1 DAG %
Senast
1 mån
